AAAAAA

   
Results: 1-12 |
Results: 12
RELATIVE BIOAVAILABILITY OF ONDANSETRON 8-MG ORAL TABLETS VERSUS 2 EXTEMPORANEOUS 16-MG SUPPOSITORIES - FORMULATION AND GENDER DIFFERENCES
Authors: JANN MW ZUMBRUNNEN TL TENJARLA SN WARD ES WEIDLER DJ
Citation: Mw. Jann et al., RELATIVE BIOAVAILABILITY OF ONDANSETRON 8-MG ORAL TABLETS VERSUS 2 EXTEMPORANEOUS 16-MG SUPPOSITORIES - FORMULATION AND GENDER DIFFERENCES, Pharmacotherapy, 18(2), 1998, pp. 288-294
SHORT-TERM COMPARISON OF ONCE-DAILY VERSUS TWICE-DAILY ADMINISTRATIONOF GLIMEPIRIDE IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: SONNENBERG GE GARG DC WEIDLER DJ DIXON RM JABER LA BOWEN AJ DECHERNEY GS MULLICAN WS STONESIFER LD
Citation: Ge. Sonnenberg et al., SHORT-TERM COMPARISON OF ONCE-DAILY VERSUS TWICE-DAILY ADMINISTRATIONOF GLIMEPIRIDE IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The Annals of pharmacotherapy, 31(6), 1997, pp. 671-676
EFFECTS OF CONTROLLED-ONSET EXTENDED-RELEASE VERAPAMIL ON NOCTURNAL BLOOD-PRESSURE (DIPPERS VERSUS NONDIPPERS)
Authors: WHITE WB MEHROTRA DV BLACK HR FAKOUHI TD ELLIOTT W BYNNY RL CARR AA PRISANT M GRIMM RH HOGAN LB KAIHLANEN PM LEWIN A MAXWELL MH MERSEY JH PRATT JH PUNZI HA ROSEN JB SICA D RIPLEY B WALLIN JD WEIDLER DJ ESAYAGTENDER B
Citation: Wb. White et al., EFFECTS OF CONTROLLED-ONSET EXTENDED-RELEASE VERAPAMIL ON NOCTURNAL BLOOD-PRESSURE (DIPPERS VERSUS NONDIPPERS), The American journal of cardiology, 80(4), 1997, pp. 469-474
NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION (VOL 76, PG 375, 1995)
Authors: WHITE WB ANDERS RJ MACINTYRE JM BLACK HR SICA DA BYNNY RL CARR AA GRIMM RH HOGAN LB KAIHLANEN PM LEWIN A MAXWELL MH MERSEY JH PRATT JH PUNZI HA ROSEN JB WALLIN JD WEIDLER DJ
Citation: Wb. White et al., NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION (VOL 76, PG 375, 1995), The American journal of cardiology, 77(11), 1996, pp. 1030-1030
LISINOPRIL VERSUS PLACEBO IN THE TREATMENT OF HEART-FAILURE - THE LISINOPRIL HEART-FAILURE STUDY-GROUP
Authors: BELLER B BULLE T BOURGE RC COLFER H FOWLES RE GILES TD GROVER J WHIPPLE JP FISHER MB JESSUP M NAGGAR C ALEXANDER S PARKER BM SMITH E WEIDLER DJ WERTHEIMER J
Citation: B. Beller et al., LISINOPRIL VERSUS PLACEBO IN THE TREATMENT OF HEART-FAILURE - THE LISINOPRIL HEART-FAILURE STUDY-GROUP, Journal of clinical pharmacology, 35(7), 1995, pp. 673-680
INTERMITTENT TRANSDERMAL NITROGLYCERIN THERAPY IN ANGINA-PECTORIS - CLINICALLY EFFECTIVE WITHOUT TOLERANCE OR REBOUND
Authors: PARKER JO AMIES MH HAWKINSON RW HEILMAN JM HOUGHAM AJ VOLLMER MC WILSON RR BAIRD MG FRASER M CHRYSANT S CHRYSANT C DEMOTS H KEETON B DETRANO R VAITOVAS B DEABATE CA MANNING B ELSHAHAWY MA WHEELER J FRISHMAN WH FURIA S GARLAND WT ALLIPRANDINI J GLASER AL SCREWS BA GROSSMAN WJ FLETCHER K JUNEAU M LARIVEE L KENNEY JS KEREIAKES DJ MARTIN L ANDERSON L KLINKE WP KVILL L KOSTUK W KENNEDY R LOPEZ JF KUNY P MA P FILIPCHUK NG GROSE M MARANDA C GRAHAM E FARRELL B PARKER T WATKINS T SHELL WE KAPIT A SMITH WB SERPAS T TAYLOR J OLSSON C UNGER C PONTI P VIJAY N WASHAM M WARNICA JW SMITH B WEIDLER DJ JALLAD NS WILLIAMS DL TRACY D MARTIN D ZELLNER SR MICHIE DD YOUNGER G
Citation: Jo. Parker et al., INTERMITTENT TRANSDERMAL NITROGLYCERIN THERAPY IN ANGINA-PECTORIS - CLINICALLY EFFECTIVE WITHOUT TOLERANCE OR REBOUND, Circulation, 91(5), 1995, pp. 1368-1374
NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION
Authors: WHITE WB ANDERS RJ MACINTYRE JM BLACK HR SICA DA BYNNY RL CARR AA GRIMM RH HOGAN LB KAIHLANEN PM LEWIN A MAXWELL MH MERSEY JH PRATT JH PUNZI HA ROSEN JB WALLIN JD WEIDLER DJ
Citation: Wb. White et al., NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION, The American journal of cardiology, 76(5), 1995, pp. 375-380
AMLODIPINE IN CHRONIC STABLE ANGINA - RESULTS OF A MULTICENTER DOUBLE-BLIND CROSSOVER TRIAL
Authors: EZEKOWITZ MD HOSSAK K MEHTA JL THADANI U WEIDLER DJ KOSTUK W AWAN N GROSSMAN W BOMMER W
Citation: Md. Ezekowitz et al., AMLODIPINE IN CHRONIC STABLE ANGINA - RESULTS OF A MULTICENTER DOUBLE-BLIND CROSSOVER TRIAL, The American heart journal, 129(3), 1995, pp. 527-535
PHARMACODYNAMIC ACTIVITY OF INTRAVENOUS E-3174, AN ANGIOTENSIN-II ANTAGONIST, IN PATIENTS WITH ESSENTIAL-HYPERTENSION
Authors: SWEET CS BRADSTREET DC BERMAN RS JALLARD N SAENZ A WEIDLER DJ
Citation: Cs. Sweet et al., PHARMACODYNAMIC ACTIVITY OF INTRAVENOUS E-3174, AN ANGIOTENSIN-II ANTAGONIST, IN PATIENTS WITH ESSENTIAL-HYPERTENSION, American journal of hypertension, 7(12), 1994, pp. 1035-1040
PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF FLOSEQUINAN IN PATIENTSWITH HEPATIC-DYSFUNCTION
Authors: HINSON JL HIND ID WEIDLER DJ
Citation: Jl. Hinson et al., PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF FLOSEQUINAN IN PATIENTSWITH HEPATIC-DYSFUNCTION, Journal of pharmaceutical sciences, 83(3), 1994, pp. 382-385
EFFICACY OF MISOPROSTOL IN CONTROLLING INDOMETHACIN-INDUCED FECAL BLOOD-LOSS IN ARTHRITIC PATIENTS
Authors: JALLAD NS CATTAN A WEIDLER DJ
Citation: Ns. Jallad et al., EFFICACY OF MISOPROSTOL IN CONTROLLING INDOMETHACIN-INDUCED FECAL BLOOD-LOSS IN ARTHRITIC PATIENTS, International journal of clinical pharmacology, therapy and toxicology, 31(8), 1993, pp. 376-381
THE AMERICAN-BOARD-OF-CLINICAL-PHARMACOLOGY-INC
Authors: SHEPHERD AMM WEIDLER DJ
Citation: Amm. Shepherd et Dj. Weidler, THE AMERICAN-BOARD-OF-CLINICAL-PHARMACOLOGY-INC, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 117-122
Risultati: 1-12 |